The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been endorsed by the ANZCTR. Before participating in a study, talk to your health care provider and refer to this information for consumers
Trial registered on ANZCTR


Registration number
Help: Registration number
ACTRN12626000752369
Ethics application status
Help: Ethics application status
Approved
Date submitted
Help: Date submitted
1/05/2026
Date registered
Help: Date registered
24/06/2026
Date last updated
Help: Date last updated
24/06/2026
Date data sharing statement initially provided
Help: Data sharing statement date
24/06/2026
Type of registration
Help: Type of registration
Prospectively registered

Titles & IDs
Public title
The effect of water dousing on heat strain after exercise in trained cyclists
Scientific title
The effect of water dousing on heat strain after exercise in trained cyclists
Additional trial identifiers [1] 317108 0
Nil known
Universal Trial Number (UTN)
Trial acronym
Related trial records

Health condition
Health condition(s) studied:
Heat illness 341653 0
Condition category
Condition code
Injuries and Accidents 337744 337744 0 0
Other injuries and accidents

Intervention/exposure
Study type
Interventional
Description of the intervention or exposure
Materials and procedures:
-Once enrolled into the study, participants will complete one familiarisation session and two experimental trials in an environmental chamber. Every session will involve only an individual participant completing the trials.

-Each experimental session will take approximately a total of 3 to 4 hours and are undertaken 3-7 days apart. Data collected for this particular study is nested within larger project sessions.

-A familiarisation session will occur 3-7 days prior to the first experimental session for the broader project and take approximately 3 hours. This will include participants completing an incremental test to exhaustion and a 30km time trial on the bike. The incremental test to exhaustion will be conducted in temperate conditions (22°C and 50% relative humidity) on bicycle ergometer with a metabolic cart to measure gas exchange. The test will consist of an initial four minute submaximal steady state exercise intensity, followed by the power output increasing by 25 W every minute until volitional exhaustion.

- The two experimental sessions (intervention and control) require the participant to complete recovery cooling following both a 30km self-paced time trial and a 48 min fixed-intensity (65% of maximal oxygen consumption) cycle (i.e. two separate moments in the broader trial) in an environmental chamber set to 35°C and 20 % relative humidity.

Recovery 1: Douse (intervention) vs no-douse (control)
Immediately after the 30 km time-trial, a 30 min recovery period will begin where dousing or control (see details below) will occur at baseline and then every six minutes whilst undertaking passive rest (i.e. sitting on a chair; 5 total douses). Each douse will involve pouring 500 ml of water on the arms, upper legs, chest and back of the neck. The water will be approximately equal to air temperature (i.e. will not be cooled [~35°C]). A fan will be set to 10.2 km/h to mimic a light breeze and the participants will drink 150 ml of water every 6 min to simulate typical post-event water consumption. The consumed water will be 38°C.

A further 30 min break where no experimental data will be collected will occur prior to beginning the 48 min fixed intensity cycling (at 65 % of maximal oxygen consumption).

Recovery 2: Cold douse (intervention) vs cold drink (comparator)
Following the 48 min fixed intensity exercise, a mixed-methods cooling design whereby both experimental trials will include a cold ice towel (~2.5 kg) being placed on the participant’s neck with the addition of either cold water dousing or the ingestion of cold water. The participants will consume 150 ml of 38°C water immediately after completing the fixed-intensity cycle, The ingested water will be 38°C to ensure that there is no cooling effect from the water consumed. The dousing protocol will involve spreading the water over the same body locations as recovery period 1, however the total volume will be 200ml each douse and the temperature of dousing water will be equivalent to the comparator cold drinking water trial (~10°C). A total of 1000ml will be doused over the 30 min across 5 total douses. The cold ice towel will be only placed around the neck for the first 6 min of the recovery. A fan will be set to maintain an air velocity of ~0.5-2.0 km/h.

Who will deliver:
A sport science graduate will lead data collection, and the remainder of the team are experienced researchers with 10-20 years of academic experience.

Mode:
In-person testing of individual participants

Location:
Environmental chamber at the Mile End campus of Adelaide University.

Adherence:
Research team member/s will supervise the participants at all times in the environmental chamber to ensure adherence to the study protocols.
Intervention code [1] 333945 0
Prevention
Intervention code [2] 334337 0
Treatment: Other
Description of the comparator or control
Description of the comparator or control:
Recovery 1: Douse vs no-douse
The same procedure will be followed in the second experimental trial except there will be no dousing (control). The participants will still drink the same prescribed post-exercise water as the douse (intervention) trial and be exposed to the same air velocity.

Recovery 2: Cold douse vs Cold drink
The participants will consume 150 ml of 38°C water immediately after completing the fixed-intensity cycle, Afterwards, rather than dousing ~10°C water, participants will consume it at the start of the 30 min recovery and every 6 min, for a total of 1150 ml (comparator).
Control group
Active

Outcomes
Primary outcome [1] 345289 0
Core temperature (directly measured)
Timepoint [1] 345289 0
Monitored continuously during the entire duration of each session across the experimental sessions. An ingestible sensor is consumed 6-8 hours prior to each session.
Secondary outcome [1] 461173 0
Heart rate
Timepoint [1] 461173 0
Fitted at the start of the trial and then monitored continuously during the entire duration of each session
Secondary outcome [2] 461174 0
Thermal sensation
Timepoint [2] 461174 0
Baseline (start of recovery) and then every 6 minutes
Secondary outcome [3] 461175 0
Thermal discomfort
Timepoint [3] 461175 0
Baseline (start of recovery) and then every 6 minutes.
Secondary outcome [4] 461176 0
Skin temperature
Timepoint [4] 461176 0
Fitted at the start of the session and then monitored continuously during the entire session duration.
Secondary outcome [5] 461177 0
Whole body sweat loss
Timepoint [5] 461177 0
Before and after the recovery period
Secondary outcome [6] 461178 0
Blood pressure
Timepoint [6] 461178 0
Measured at the start and end of the recovery period
Secondary outcome [7] 461179 0
Maximal oxygen consumption (VO2max)
Timepoint [7] 461179 0
During the incremental test to exhaustion
Secondary outcome [8] 461180 0
Core temperature (estimated)
Timepoint [8] 461180 0
Monitored continuously for the entirety of the observation periods during each trial
Secondary outcome [9] 461181 0
Water not stuck to participant
Timepoint [9] 461181 0
Following each douse during recovery period 1 and 2

Eligibility
Key inclusion criteria
The participants will be trained cyclists (at least tier 2 according to McKay et al. framework) aged between18-55 years old.
Minimum age
18 Years
Maximum age
55 Years
Sex
Both males and females
Healthy volunteers
Yes
Key exclusion criteria
-Not passing Stage 1 of the ESSA pre-exercise screening tool.
-Prior diagnosed case of exertional heat stroke
-Current musculoskeletal injury

Study design
Purpose of the study
Prevention
Allocation to intervention
Randomised controlled trial
Procedure for enrolling a subject and allocating the treatment (allocation concealment procedures)
No allocation concealment
Methods used to generate the sequence in which subjects will be randomised (sequence generation)
Since the study is a crossover design, participants are not randomly allocated to groups, but randomly allocated the trial order via blocked randomisation. Blocked randomisation (without blinding) by the lead data collector
Masking / blinding
Open (masking not used)
Who is / are masked / blinded?



Intervention assignment
Crossover
Other design features
Phase
Not Applicable
Type of endpoint/s
Efficacy
Statistical methods / analysis
Null hypothesis testing to compare the participant responses using common statistical approaches to the Sport Science literature.

Recruitment
Recruitment status
Not yet recruiting
Date of first participant enrolment
Anticipated
Actual
Date of last participant enrolment
Anticipated
Actual
Date of last data collection
Anticipated
Actual
Sample size
Target
Accrual to date
Final
Recruitment in Australia
Recruitment state(s)
SA

Funding & Sponsors
Funding source category [1] 321691 0
University
Name [1] 321691 0
Adelaide University
Country [1] 321691 0
Australia
Primary sponsor type
University
Name
Adelaide University
Address
Country
Australia
Secondary sponsor category [1] 324596 0
None
Name [1] 324596 0
Address [1] 324596 0
Country [1] 324596 0
Other collaborator category [1] 283924 0
University
Name [1] 283924 0
Hong Kong Baptist University
Address [1] 283924 0
Country [1] 283924 0
Hong Kong

Ethics approval
Ethics application status
Approved
Ethics committee name [1] 320227 0
University of South Australia Human Research Ethics Committee
Ethics committee address [1] 320227 0
Ethics committee country [1] 320227 0
Australia
Date submitted for ethics approval [1] 320227 0
22/10/2025
Approval date [1] 320227 0
25/11/2025
Ethics approval number [1] 320227 0
207406

Summary
Brief summary
Trial website
Trial related presentations / publications
Public notes

Contacts
Principal investigator
Name 149822 0
Dr Samuel Chalmers
Address 149822 0
Adelaide University, Level 2, SASI Building, 145B Railway Terrace, Mile End SA 5031.
Country 149822 0
Australia
Phone 149822 0
+61 08 8302 1307
Fax 149822 0
Email 149822 0
Contact person for public queries
Name 149823 0
James Way
Address 149823 0
Adelaide University, Level 2, SASI Building, 145B Railway Terrace, Mile End SA 5031.
Country 149823 0
Australia
Phone 149823 0
+61 08 8302 1307
Fax 149823 0
Email 149823 0
Contact person for scientific queries
Name 149824 0
Samuel Chalmers
Address 149824 0
Adelaide University, Level 2, SASI Building, 145B Railway Terrace, Mile End SA 5031.
Country 149824 0
Australia
Phone 149824 0
+61 08 8302 1307
Fax 149824 0
Email 149824 0

Data sharing statement
Will the study consider sharing individual participant data?
Yes
Will there be any conditions when requesting access to individual participant data?
Persons/groups eligible to request access:
• Researchers
Conditions for requesting access:
• Yes, conditions apply:
• Requires review on a case-by-case basis by the trial custodian, sponsor or data sharing committee
What individual participant data might be shared?
• De-identified individual participant data:
• Published results
What types of analyses could be done with individual participant data?
• Systematic reviews and meta-analyses
When can requests for individual participant data be made (start and end dates)?
From:
After publication of main results
To:
A finite period of: 5 years
Where can requests to access individual participant data be made, or data be obtained directly?
• Email of trial custodian, sponsor or committee: [email protected]

Are there extra considerations when requesting access to individual participant data?
No


What supporting documents are/will be available?

No Supporting Document Provided


Results publications and other study-related documents

Documents added manually
No documents have been uploaded by study researchers.

Documents added automatically
No additional documents have been identified.